TCL Archive Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure August 12, 1988
TCL Archive Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects June 20, 1980
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive University of Pittsburgh honors breast cancer surgeon and clinical trialist Bernard Fisher with lecture and portrait. May 13, 2005
